A new study led by MBI researchers has found that using certain FDA-approved medications for addiction treatment was not associated with worse outcomes or additional impairment among participants in Florida’s physician health program.
Longtime faculty member, medical director of Florida Recovery Center, passed away April 16.
Chief of UF addiction research and director of UF's CARE Center, has been elected a 2025 AAAS Fellow.
In The Conversation, Drs. Habibeh Khoshbouei and Marcelo Febo discuss their new study paving the way to test immune-modulating medicines as a potential tool to break the cycle of meth addiction.
An MBI research team made a preclinical discovery paving the way to test immune-modulating medicines as a tool to break the cycle of meth addiction.
In The New York Times, Dr. Sara Jo Nixon discusses how alcohol impacts the body as you age.
Dr. Martinez-Rivera's research aims to broaden understanding of adaptive as well as dysfunctional behaviors in conditions such as substance-use disorder, depression and obsessive-compulsive disorder.
Drs. Linda Cottler, Lori Knackstedt, and Barry Setlow recognized for top articles on addiction research in 2024.
Dr. Sara Jo Nixon co-authored a paper that was recently honored with the 2023 Charles A. Lewis Excellence in Research Award.
Drs. Michael Okun (Lifetime Achievement Award) and Anthony Yachnis (collegewide Clinical Excellence Award) among researchers recognized.
